Exchanges

Mizuho seeks $350 million from TSE

Mizuho Securities is demanding ¥40.4 billion ($347 million) from the Tokyo Stock Exchange (TSE) to compensate it for a trading error that it was unable to cancel on time.

Mizuho seeks $350 million from TSE

Mizuho Securities is demanding ¥40.4 billion ($347 million) from the Tokyo Stock Exchange (TSE) to compensate it for a trading error that it was unable to cancel on time.

Fortis Chicago merges with O'Connor and Company

Benelux bancassurer Fortis has completed its acquisition of O’Connor and Company, the Chicago-based clearing house. The new company is called Fortis Clearing Americas and will be run within Fortis’ merchant banking division.

Chinese brokers to set up in Hong Kong

Six Chinese futures brokerages will soon get the green light to start derivatives broking operations in Hong Kong, a source close to the Hong Kong Exchanges and Clearing (HKEx) tells RiskNews .

Kick-start for coal futures

Ice Futures and the European Energy Exchange have gone head-to-head in the latest attempt to kick-start coal derivatives trading. Oliver Holtaway investigates

Making green with ethanol

Financial investors and commodity traders are paying closer attention to the US corn crop, due to the potential impacts it may have on the growing ethanol market. Daven Voorhies explains

L Sankar, Jure Skarabot

Citigroup credit derivatives specialists explain why the Gaussian copula model, despite its flaws, is still the market standard for analysing correlation

Swiss restructuring

As regulatory pressure on insurance companies to improve their solvency requirements increases, one reinsurer's reaction stands out from the crowd. Hardeep Dhillon looks at how Swiss Re is using innovative structures in the debt capital markets to…

Overcoming the barriers to a CDS futures market

The long-awaited CDS futures contract from Eurex has suffered repeated setbacks. Initially planned for launch last year, it is yet to make an appearance. Sell-side inertia, documentation disputes and a booming OTC market are some of the obstacles it…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here